Kisha Sivanathan, a PhD student leading a team of researchers at the University of Adelaide, Australia, identified a major breakthrough in the cultivation and application of mesenchymal stem cells [MSC]. The research group looked at the interaction between MSCs and IL-17, a naturally occurring protein that occurs in the body during immune responses. The cells treated with IL-17 not only showed faster growth rates, but prevented the risk of potential rejection of stem cell tissue transplants.
